Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic optimization of voriconazole with therapeutic drug monitoring
2008-007973-19Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hematopoietic malignancies and invasive mycoses comparing Sequence starting with TDM-guided voriconazole with Sequence starting with standard of care voriconazole (2 arms). Primary endpoint: Global treatment failure by day 28. Started Jan 2009; status: active.
02
Drugs
voriconazole
03
Conditions
hematopoietic malignanciesinvasive mycoses
Beyond the preview
Go deeper on 2008-007973-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007973-19.